APOE ε4 allele advances the age-dependent decline of amyloid β clearance in the human cortex
Saito, A.; Kageyama, Y.; Pletnikova, O.; Rudow, G. L.; An, Y.; Irie, Y.; Kita, A.; Miki, K.; Li, L.; Southall, P.; Irie, K.; Troncoso, J. C.
Show abstract
IntroductionOur previous study indicated that the pericapillary clearance of amyloid {beta} (A{beta}) declines with age in APOE 3/3 subjects. Here, we examine whether the APOE {varepsilon}4 allele has an impact on this age-related decline. MethodsWe examined 69 autopsy brains of APOE {varepsilon}3/{varepsilon}4 or APOE {varepsilon}3/{varepsilon}3 individuals (30-65 years) for the immunohistochemical localization of intracellular, extracellular, and pericapillary A{beta} in the cerebral cortex. ResultsIn APOE {varepsilon}3/{varepsilon}4 individuals, the percentage of A{beta} positive pericapillary spaces began to decrease (p=0.030), and the number of extracellular A{beta} particles increased in the early 30s (p=0.0008). Those average values were significantly lower (p<0.0001) and higher (p<0.0001), respectively, compared to APOE {varepsilon}3/{varepsilon}3 individuals. DiscussionOur observations indicate that APOE {varepsilon}4 allele advances by one decade at the onset of age-related decline in A{beta} glymphatic clearance. This finding supports early clinical intervention and stratification by APOE genotype to prevent A{beta} deposition and AD progression.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- C5aR1 antagonism alters microglial polarization and mitigates disease progression in a mouse model of Alzheimers disease 95%
- Distinctive retinal peri-arteriolar versus peri-venular amyloid plaque distribution correlates with the cognitive performance 95%
- Protein farnesylation is upregulated in Alzheimer's human brains and neuron-specific suppression of farnesyltransferase mitigates pathogenic processes in Alzheimer's model mice 95%
Similar papers in this journal
- Rare genetic variation in Fibronectin 1 (FN1) protects against APOEe4 in Alzheimer's disease 96%
- Low circulating choline, a modifiable dietary factor, is associated with the pathological progression and metabolome dysfunction in Alzheimers disease. 96%
- Apolipoprotein E abundance is elevated in the brains of individuals with Down syndrome-Alzheimer's disease 95%
Similar papers in this journal
- Age, Sex and Alzheimer's disease: A longitudinal study of 3xTg-AD mice reveals sex-specific disease trajectories and inflammatory responses mirrored in postmortem brains from Alzheimer's patients 95%
- Increased cerebrospinal fluid and plasma apoE glycosylation is associated with reduced levels of Alzheimer's disease biomarkers 94%
- Behavioural and transcriptomic characterization of the comorbidity between Alzheimer s disease and Major Depression 94%
Similar papers in this journal
- Susceptibility to postmortem (co)-pathologies in antemortem atrophy-based subtypes of Alzheimer’s disease 93%
- CSF Aβ38 levels are associated with Alzheimer-related decline: implications for γ-secretase modulators 93%
- CSF p-tau181 Increases in Patients with Neuronal Intranuclear Inclusion Disease without Amyloid Burden 92%
Similar papers in this journal
- Evaluation of CB2R expression and pyridine-based radiotracers in brains from a mouse model of Alzheimer's disease 94%
- Cortical cerebrovascular and metabolic perturbations in the 5xFAD mouse model of Alzheimer's disease 94%
- Dual-specificity protein phosphatase 6 (DUSP6) overexpression reduces amyloid load and improves memory deficits in male 5xFAD mice 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.